​

Kyverna Therapeutics (KYTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Kyverna Therapeutics Revenue Highlights

00

Kyverna Therapeutics Revenue by Period

Kyverna Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$7.03M24.20%
2021-12-31$5.66M-

Kyverna Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Kyverna Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$2.02M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$282.00K-

Kyverna Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Kyverna Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SLNSilence Therapeutics$43.26M$224.00K
CAPRCapricor Therapeutics$22.27M-
ALLOAllogene Therapeutics$22.00K-
EDITEditas Medicine--
CABACabaletta Bio--
KYTXKyverna Therapeutics--
CTNMContineum Therapeutics, Inc. Class A--
LXEOLexeo Therapeutics--
LYELLyell Immunopharma-$8.00K
MREOMereo BioPharma Group-$500.00K
AVIRAtea Pharmaceuticals--

KYTX Revenue FAQ

What is Kyverna Therapeutics’s yearly revenue?

Kyverna Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. KYTX's yearly revenue for 2022 was $7.02M, representing an increase of 24.20% compared to 2021.

What is Kyverna Therapeutics’s quarterly revenue?

Kyverna Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). KYTX's quarterly revenue for Q4 2024 was $2.02M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Kyverna Therapeutics’s revenue growth rate?

Kyverna Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%